**Core Concept**
Heparin therapy requires monitoring to prevent both thrombosis and bleeding due to its narrow therapeutic window. The most commonly used method for monitoring heparin levels is by measuring its effect on coagulation through activated partial thromboplastin time (aPTT) or anti-factor Xa levels.

**Why the Correct Answer is Right**
The correct answer is **anti-factor Xa levels**. This is because heparin exerts its anticoagulant effect by binding to antithrombin III and inhibiting the coagulation cascade, specifically factor Xa. Measuring anti-factor Xa levels provides a more direct assessment of heparin's anticoagulant activity and is less susceptible to variations in clotting factor levels. This is particularly useful in patients with renal failure, as heparin's clearance is primarily renal.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because aPTT is a commonly used method for monitoring heparin therapy, but it is not the most specific or direct measure of heparin's anticoagulant activity.

**Option B:** This option is incorrect because PT (prothrombin time) is a measure of the extrinsic coagulation pathway and is not directly related to heparin's anticoagulant effect.

**Option C:** This option is incorrect because INR (International Normalized Ratio) is a measure of the extrinsic and common coagulation pathways and is not specific to heparin therapy.

**Clinical Pearl / High-Yield Fact**
In patients with renal failure, anti-factor Xa levels should be used to monitor heparin therapy, as aPTT may be prolonged due to accumulation of clotting factors.

**Correct Answer:** D. anti-factor Xa levels